Faulkner, Matthew
Andrews, Fraser
Scrutton, Nigel
Funding for this research was provided by:
Engineering and Physical Sciences Research Council (EP/S01778X/1)
Article History
Received: 4 October 2024
Accepted: 21 November 2024
First Online: 5 December 2024
Declarations
:
: Not applicable.
: Not applicable.
: N.S.S. is a board member and cofounder of C3 Biotechnologies Ltd, and shareholder of C3 Biotechnologies Ltd.